Abstract

Objective:Immediate single instillation of chemotherapy following transurethral resection of bladder tumor (TURBT) is suggested for non-muscle invasive bladder cancer (NMIBC) patients. However, no study has evaluated molecular marker that was involved in intravesical recurrence (IVR) after single instillation of chemotherapy. Therefore, this study aimed to evaluate whether P-glycoprotein, multidrug resistance protein 1 (MRP1), Annexin A2 (ANXA2) or nucleophosmin (NPM) expression predicts IVR after initial TURBT and immediate single intravesical adriamycin instillation. Methods:We retrospectively reviewed consecutive 443 patients who underwent TURBT. Of these, 54 patients who underwent initial TURBT and single instillation of adriamycin for NMIBC were included. The expressions of P-glycoprotein, MRP1, ANXA2 and NPM were evaluated immunohistochemically and were divided into 2 groups (low or high) according to the staining intensity and/or proportion of positive cells. IVR was assessed by Kaplan-Meier method. Cox`s multivaritate analyses were performed to identify independent predictors for IVR. Results: Nineteen patients (35.1%) had IVR. High P-glycoprotein expression was significantly correlated with multiplicity, pT stage and high grade. High ANXA2 expression was significantly correlated with high grade. MRP1 and NPM were not correlated with any clinicopathological variables. MRP1 expression and ANXA2 expression were significantly correlated with P-glycoprotein expression. Patients with high P-glycoprotein expression had significantly worse IVR-free survival (IVRFS) than those with low P-glycoprotein expression (P =0.015). The difference in IVRFS rates between patients with high ANXA2 expression and those with low ANXA2 expression was nearly significant (P =0.057). Univariate analyses indicated multiplicity, high grade and high P-glycoprotein expression were significant predictors for IVR. Multivariate analysis indicated high grade was an independent predictor for IVR. Conclusions: High P-glycoprotein expression was associated with IVR. Further study was needed to determine significance of P-glycoprotein expression in IVR after single intravesical adriamycin instillation.

Highlights

  • GLOBOCAN data revealed that an estimated 550,000 people were diagnosed with bladder cancer globally in 2018

  • We evaluated the association between expression of the four proteins and intravesical recurrence (IVR) in patients with initial transurethral resection of bladder tumor (TURBT) and immediate single postoperative intravesical adriamycin instillation

  • P-glycoprotein, multidrug resistance protein 1 (MRP1) and MRP3 mRNA expressions in clinical samples of bladder cancer were significantly correlated with drug resistance of the cancer cells to adriamycin

Read more

Summary

Introduction

GLOBOCAN data revealed that an estimated 550,000 people were diagnosed with bladder cancer globally in 2018. MRNA and protein levels of P-glycoprotein and MRP1 were reportedly over-expressed in recurrent tumors after TURBT plus prophylactic intravesical adriamycin instillation and in residual tumors after systemic chemotherapy using methotrexate, vincristine, adriamycin and cisplatin (Tada et al, 2002). Overexpressions of ANXA2 and NPM were identified in adriamycin-resistant human bladder cancer cell lines by proteome analysis. Both ANXA2 and NPM may take part in the mechanism of MDR in bladder cancer (Meng et al, 2013). The aims of this study were to investigate whether P-glycoprotein, MDR1, ANXA2 or NPM expression predicts IVR after initial TURBT and single postoperative intravesical adriamycin instillation

Materials and Methods
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call